Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,035
datasets available to search
ShareScore release 0.9.0
Dataset results
1,035 results for “cancer invasion”
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT06331299. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations
ClinicalTrials.gov study NCT06511648. IPD Sharing: NO. Countries: 4. Publications: 0.
Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active Surveillance
ClinicalTrials.gov study NCT03956108. IPD Sharing: NO. Countries: 1. Publications: 0.
Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile
ClinicalTrials.gov study NCT06452745. IPD Sharing: NO. Countries: 1. Publications: 0.
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
ClinicalTrials.gov study NCT02852564. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
ClinicalTrials.gov study NCT05975307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
ClinicalTrials.gov study NCT04799847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT06510374. IPD Sharing: NO. Countries: 5. Publications: 0.
Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT06916494. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT05072600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04671407. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Ba
ClinicalTrials.gov study NCT03335059. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture
ClinicalTrials.gov study NCT04583553. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT05014139. IPD Sharing: NO. Countries: 6. Publications: 0.
Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx
ClinicalTrials.gov study NCT00675233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
ClinicalTrials.gov study NCT07148154. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients
ClinicalTrials.gov study NCT03799835. IPD Sharing: NO. Countries: 3. Publications: 0.
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
ClinicalTrials.gov study NCT05900986. IPD Sharing: NO. Countries: 1. Publications: 0.
Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy
ClinicalTrials.gov study NCT03993249. IPD Sharing: NO. Countries: 1. Publications: 0.
IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer
ClinicalTrials.gov study NCT03748680. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.